logo_image
Headline: Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
Location: Farmington Hills, MI, US
Post Date: Apr 8, 2021 8:31 AM
TAG ID: pznews221849
DocID: 202104088213718-en.xml
Word Count: approx. 1649 words
 
Ocuphire Initiates ZETA-1 Phase 2 Clinical Trial Investigating APX3330 in Diabetic Retinopathy
 
Please login to download this Story